Long-Acting Thyroid Stimulator
Showing 1 - 25 of >10,000
Diabetes, Diabetes, Type 2, Medullary Thyroid Carcinoma Trial in Morgantown (No treatment given)
Enrolling by invitation
- Diabetes
- +3 more
- No treatment given
-
Morgantown, West VirginiaUnited BioSource, LLC
Oct 4, 2022
Erythropoiesis Stimulating Agents for Anemia Management in
Completed
- Anemia of Chronic Kidney Disease
- +2 more
-
Giza, Egyptthe Memorial Souad Kafafi University Hospital
Jan 24, 2023
Anesthetics, Local Trial in New York (lidocaine + epinephrine 1:100,000, Ropivacaine 0.2% Injectable Solution, Bupivacaine 0.5%
Not yet recruiting
- Anesthetics, Local
- lidocaine + epinephrine 1:100,000
- +2 more
-
New York, New YorkWeill Cornell Medicine
Mar 2, 2023
Thyroid Auto Transplantation Following Total Thyroidectomy in
Enrolling by invitation
- Thyroid Diseases
- total thyroidectomy followed by thyroid auto transplantation
-
Sohag, EgyptSohag University
Jun 26, 2023
Hiv Trial in United States (Self-guided health education, Patient-provider decision tool, Provider-guided education)
Not yet recruiting
- Hiv
- Self-guided health education
- +2 more
-
Bronx, New York
- +5 more
Apr 17, 2023
Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir Injectable Suspension, Rilpivirine Injectable
Completed
- Human Immunodeficiency Virus Type 1 (HIV-1)
- Cabotegravir Injectable Suspension
- Rilpivirine Injectable Suspension
-
Bakersfield, California
- +31 more
May 31, 2023
Cisgender Female Patients Who Start on Long Acting Cabotegravir
Not yet recruiting
- Hiv
- Cabotegravir Injection [Apretude]
-
Orlando, Florida
- +2 more
Nov 17, 2023
Kidney Stone Trial in Bern (Indapamide 2.5 MG, Hydrochlorothiazide 50Mg, Chlorthalidone 25mg)
Not yet recruiting
- Kidney Stone
- Indapamide 2.5 MG
- +2 more
-
Bern, SwitzerlandInselspital, Department of Nephrology and Hypertension
Oct 26, 2023
COPD Greek Patients Based on Standard Clinical Practice.
Not yet recruiting
- Copd
- COPD Exacerbation
- (no location specified)
Jun 22, 2022
Chronic Pain Trial in United States (Boston Scientific Spectra WaveWriter SCS System)
Terminated
- Chronic Pain
- Boston Scientific Spectra WaveWriter SCS System
-
Phoenix, Arizona
- +5 more
Jan 21, 2022
HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))
Recruiting
- HIV Infections
- Oral Cabotegravir (CAB)
- +4 more
-
La Jolla, California
- +30 more
Feb 2, 2023
HIV-1-infection, HIV, HIV I Infection Trial (CAB + RPV)
Not yet recruiting
- HIV-1-infection
- +2 more
- CAB + RPV
- (no location specified)
Nov 16, 2022
A Retrospective rEal-life daTa Study to Assess exaceRbations and
Completed
- COPD
- COPD Exacerbation
-
Thessaloniki, GreecePapanikolaou Hospital of Thessaloniki
Sep 7, 2022
Asthma Trial in Spain (To compare in both treatment arms the percentage of patients controlled at week 52.)
Recruiting
- Asthma
- To compare in both treatment arms the percentage of patients controlled at week 52.
-
Inca, Baleares, Spain
- +16 more
Jun 16, 2023
Thyroid Profiles in Patients With Acute Illness
Not yet recruiting
- Thyroid Dysfunction
- Acute Illness
- Performing blood thyroid test (TSH, FT4, FT3)
-
Amman, JordanIstishari Hospital
Aug 7, 2023
Uncontrolled Asthma Trial (Experimental: CHF6001 3200 µg, Placebo Comparator: CHF6001 Placebo)
Not yet recruiting
- Uncontrolled Asthma
- Experimental: CHF6001 3200 μg
- Placebo Comparator: CHF6001 Placebo
- (no location specified)
Sep 7, 2023
Rhinoplasty, Pain Management Trial in Hershey (Liposomal Bupivacaine, 0.25% bupivacaine with 1:200,000 epinephrine, Placebo -
Not yet recruiting
- Rhinoplasty
- Pain Management
- Liposomal Bupivacaine
- +2 more
-
Hershey, PennsylvaniaJessyka Lighthall
Jul 19, 2023
Copd Trial in Assiut (SABA SAMA ICS Vs LABA LAMA ICs)
Not yet recruiting
- Copd
- SABA SAMA ICS Vs LABA LAMA ICs
-
Assiut, EgyptNermen Mohammed Abuelkassem
Feb 28, 2023
Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)
Completed
- Pancreatic Neuroendocrine Tumor G2
- Octreotide LAR
- (no location specified)
Oct 17, 2023
Human Immunodeficiency Virus, Opioid Use Disorder Trial in Providence (Combined LAI Treatment: Cabenuva and Sublocade)
Recruiting
- Human Immunodeficiency Virus
- Opioid Use Disorder
- Combined LAI Treatment: Cabenuva and Sublocade
-
Providence, Rhode IslandRhode Island Hospital
Aug 7, 2023
Chronic Obstructive Pulmonary Disease (COPD) Participants
Recruiting
- Pulmonary Disease, Chronic Obstructive
- prospective observational cohort study
-
Hannover, Niedersachsen, GermanyGSK Investigational Site
Jun 20, 2022
Thyroid Cancer Trial in New York (Thyrotropin Releasing Hormone (TRH), levothyroxine, Hypothyroidism QOL questionnaire)
Recruiting
- Thyroid Cancer
- Thyrotropin Releasing Hormone (TRH)
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 12, 2022
Optimizing CAB-LA as PrEP for Women Who Inject Drugs
Recruiting
- HIV Infections
- +2 more
-
Philadelphia, PennsylvaniaPrevention Point Philadelphia
Apr 4, 2023
HIV-1-infection Trial (Etonogestrel (ENG) Subdermal Implants)
Not yet recruiting
- HIV-1-infection
- Etonogestrel (ENG) Subdermal Implants
- (no location specified)
Jul 19, 2022